The largest database of trusted experimental protocols

Annexin 5

Manufactured by Immunostep
Sourced in Spain

Annexin V is a laboratory reagent used in cell biology research. It binds to phosphatidylserine, a phospholipid that is exposed on the surface of cells undergoing apoptosis, or programmed cell death. Annexin V can be used to detect and quantify apoptotic cells.

Automatically generated - may contain errors

9 protocols using annexin 5

1

Apoptosis and Necrosis Analysis by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry was performed to identify apoptotic and necrotic profiles. A total of 20 × 103 cells per condition were gated and evaluated using a FACScalibur flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA) and a Cell Quest Pro Acquisition software (version 5.1, BD Biosciences). Using the fluorescent probes Annexin V (Immunostep, Salamanca, Spain) and propidium iodide (PI), four populations were identified: live cells (negative for both Annexin V and PI); early apoptotic cells (positive for Annexin V and negative for PI); late apoptotic cells (positive for both Annexin V and PI); and dead cells (only positive for PI). Cells were detached by trypsinization and centrifuged (550× g, 6 min), 106/mL cells were resuspended in Annexin V binding buffer (10 mM Hepes/NaOH (pH 7.4), 140 mM NaCl, 2.5 mM CaCl2), and they were incubated with Annexin V (50 µL/mL) and PI (2.5 µg/mL) for 15 min at RT, protected from light. Cells incubated overnight with 300 µM hydrogen peroxide (H2O2; Sigma-Aldrich) were used as a positive control for cell death.
+ Open protocol
+ Expand
2

Apoptosis Measurement Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Annexin V measurements were done following the manufacturer instructions: Cells from the supernatant (dead cells) were centrifuged and resuspended in Buffer 1x (Immunostep, 556454, Salamanca, Spain) Annexin V (Immunostep, 556454) was added at 5 µL/sample, and incubated for 15 min at 37 °C + 5% CO2 in darkness; DAPI was subsequently added. BioVision kits were used for caspase 8 (#K188-25; Madrid, Spain) and caspase 9 (#K189-25) in vivo activity measurements [58 (link),63 (link)]. As negative controls, z-VAD-FMK was added for every experimental condition, following the instructions of the supplier.
+ Open protocol
+ Expand
3

ADCC Capacity of PBMCs in CML Individuals

Check if the same lab product or an alternative is used in the 5 most similar protocols
Raji cell line, which was provided by the existing collection of the Instituto de Salud Carlos III (Madrid, Spain), was used as a target to determine the antibody-dependent cellular cytotoxicity (ADCC) capacity of PBMCs isolated from CML individuals and healthy donors, as described previously [20 (link)]. Briefly, Raji cells were labeled with PKH67 green fluorescent cell linker (Merck KGaA, Darmstadt, Germany) and then coated with rituximab (50 μg/mL) (Selleckhem, Houston, TX, USA) for 4 h. Labeled rituximab-coated Raji cells were then co-cultured for 18 h with PBMCs (1:2 ratio). Early apoptosis of Raji cells was evaluated via staining with Annexin V conjugated with phycoerythrin (PE) (Immunostep, Salamanca, Spain). Data acquisition was performed with a BD LSRFortessa X-20 flow cytometer and data analyses were performed with FlowJo software v10 (Tree Star Inc.).
+ Open protocol
+ Expand
4

Measurement of ADCC activity in PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibody-dependent cellular cytotoxicity (ADCC) was measured in PBMCs from the participants, as described before [23 (link)]. Briefly, Raji cells were stained with PKH67 Green Fluorescent Cell Linker (Merck KGaA, Darmstadt, Germany) and then coated with rituximab (50 μg/mL) (Selleckhem, Houston, TX, USA). Rituximab-coated Raji cells were co-cultured with PBMCs (1:2 ratio) for 18 h. Early apoptosis induced by PBMCs in Raji cells was determined by staining with Annexin V conjugated with phycoerythrin (PE) (Immunostep, Salamanca, Spain). Analyses were performed with BD LSRFortessa X-20 flow cytometer and FlowJo software version 10.7.1 (Tree Star Inc.).
+ Open protocol
+ Expand
5

ADCC Assay of Rituximab-Coated Raji Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
ADCC assay with PBMCs from patients with different presentations of COVID-19 was performed as described before (33 (link)) with some modifications. A total of 5x105 Raji cells labeled with PKH67 Green Fluorescent Cell Linker (Merck KGaA, Darmstadt, Germany) were used as target cells. After staining, Raji cells were coated with rituximab (50µg/ml) (Selleckhem, Houston, TX) for 4 hours in the presence of 50% of pooled normal human serum (Innovative Research, Novi, MI). Labeled Raji cells were then co-cultured with PBMCs from COVID-19 patients (ratio 1:2) during 18 hours. Apoptosis of Raji cells was quantified by staining with Annexin V conjugated with 1.5 μM phycoerythrin (PE) (Immunostep, Salamanca, Spain), according to manufacturers’ instructions. Data acquisition was performed in a BD LSRFortessa X-20 flow cytometer using FACS Diva software (BD Biosciences, San Jose, CA). Data analysis was performed with FlowJo software (Tree Star Inc., Ashland, OR).
+ Open protocol
+ Expand
6

Apoptosis Quantification in Cell Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
In cell co‐cultures treated with methotrexate or cytarabine, identification and quantification of viable and apoptotic cells were carried out by flow cytometry using annexin V (ImmunoStep, Salamanca, Spain) and propidium iodide, in combination with specific primary antibodies when necessary. Cells were analysed using a FACSCalibur flow cytometer and gated according to forward scatter, side scatter, and their ability to exclude propidium iodide. Viable cells were defined as propidium iodide‐ and annexin V‐negative cells.
+ Open protocol
+ Expand
7

Cell Viability and Death Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the analysis of cell viability and types of cell death, 2 × 106 cells were collected, centrifuged, and washed with PBS prior to incubation with the binding buffer, annexin-V and propidium iodide, (Immunostep, Salamanca, Spain) for 15 min, at 4 °C in the dark. 400 mL PBS were added, the samples were analyzed in the flow cytometer using an excitation wavelength of 488 nm, and emission filters of 530/30 nm and 585/42 nm were used for annexin-V and for propidium iodide, respectively [31 (link),32 (link)]. Untreated cell cultures and cells treated with 100 and 500 µM of ZOL or ZOL/BCP for 96 and 120 h were analyzed.
+ Open protocol
+ Expand
8

Assessing hDPSC Viability Post-Bleaching

Check if the same lab product or an alternative is used in the 5 most similar protocols
To analyze cell viability of hDPSCs after treatment with the different bleaching extracts for 72 h, cells were stained with Annexin-V and 7-AAD (Immunostep, Salamanca, Spain) following manufacturer’s instructions. Subsequently, percentages of live, early or late apoptotic and necrotic cells were determined in a flow cytometer.
+ Open protocol
+ Expand
9

Annexin V Binding Assay for Apoptosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
To investigate cell surface expression of phosphatidylserine (PS), a feature of programmed cell death, an aliquot of cells previously treated, was stained with FITC-conjugated Annexin V (Immunostep, Salamanca, Spain). Washed cells were centrifuged at 1200 rpm for 5 min and the pellet resuspended in 50 µL of Annexin V Binding Buffer (10 mM Hepes/NaOH, pH 7.4; 140 mM NaCl; 2.5 mM CaCl2). Finally, 2.5 µL of Annexin V-FITC were added to the cell suspension, incubated for 15 min at room temperature and analyzed by flow cytometry.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!